vTv Therapeutics (VTVT) FCF Margin (2014 - 2026)

vTv Therapeutics (VTVT) has 11 years of FCF Margin data on file, last reported at 24.85% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin changed N/A year-over-year to 24.85%; the trailing twelve-month figure through Mar 2026 stood at 28.02% (up 13841316.0% YoY), and the FY2024 full-year result was 2476.7%, changed N/A from the prior year.
• FCF Margin climbed to 24.85% in Q1 2026, from 28200.0% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 7844.44% in Q2 2022 to a low of 76444.44% in Q4 2022.
• A 3-year average of 16259.48% and a median of 390.88% in 2022 frame the typical range for FCF Margin.
• Peak annual rise in FCF Margin reached 5226667 bps in 2022, while the deepest fall reached 514444 bps in 2022.
• Tracing VTVT's FCF Margin over 3 years: stood at 76444.44% in 2022, then soared by 63 bps to 28200.0% in 2024, then surged by 100 bps to 24.85% in 2026.
• Business Quant data shows VTVT's FCF Margin at 24.85% in Q1 2026, 28200.0% in Q4 2024, and 730.7% in Q1 2024.